Phage Cocktail for Hard-to-Treat Skin Infections
Part of Infections clinical trials.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years old
- Diagnosed skin infection with wound area between 4–225 cm² (roughly the size of a postage stamp to a playing card)
- Infection is on the skin surface only, not deep in tissues, and doesn't need surgery
- Bacteria confirmed in wound samples that resist common antibiotics or don't respond to them
- Not pregnant or breastfeeding, and willing to use contraception if able to become pregnant
- Not currently taking steroids, immunosuppressants, chemotherapy, or other drugs that weaken immunity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
This study collects and stores samples (a “biobank”) from adults who plan to receive or have already received phage therapy. It helps researchers better understand how phage therapy works and can support future treatment research.
This study tests a treatment using bacteriophages (special viruses that kill bacteria) for infections that happen around metal implants in bones. It aims to see if this approach can safely clear these hard-to-treat infections.
This trial tests whether specially designed viruses (called phages) can safely and effectively treat drug-resistant urinary tract infections. The phages are delivered directly into your bladder or kidney through a small tube, and the goal is to eliminate the infection when standard antibiotics have failed.
This study tests whether a special virus (phage) that kills bacteria can help heal infected foot ulcers in people with diabetes, when added to standard care. It may help reduce infection and improve healing.
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
Hear when a new Bacteriophage Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.